Aaron Sato, PhD, joins the BioLoomics advisory board in February 2022. Aaron is the CSO of Twist Bioscience, a company enabling customer success through its offering of high-quality synthetic DNA produced by its silicon platform. Dr. Sato’s support will help BioLoomics strengthen its strategy to ‘mine’ Biosensing drugs with the ‘Evolution in a Microscope’ technology, where DNA encoded variant drug designs are inserted into biosensing cells and tested in massively parallel live cell imaging experiments.
